GLAXOSMITHKLINE PHARMACEUTICALS Q3 FY25 Results

GLAXOSMITHKLINE PHARMACEUTICALS has released its financial results for the Q3 quarter of Financial Year 24-2025. Here's a comprehensive breakdown of the company's performance:

Revenue Analysis

• Current Quarter Revenue: Rs. 949.42 Cr
• Quarter-on-Quarter (QoQ) Change: -6.07% (Previous Quarter: Rs. 1,010.77 Cr )
• Year-on-Year (YoY) Change: 17.90% (Same Quarter Last Year: Rs. 805.26 Cr )

Profitability Metrics

• Net Profit: Rs. 229.88 Cr
• QoQ Profit Change: -8.96% (Previous Quarter: Rs. 252.50 Cr )
• YoY Profit Change: 402.80% (Same Quarter Last Year: Rs. 45.72 Cr )

Shareholder Returns

• Earnings Per Share (EPS): Rs. 13.57
• QoQ EPS Change: -7.50% (Previous Quarter: Rs. 14.67)
• YoY EPS Change: 37.21% (Same Quarter Last Year: Rs. 9.89)

Performance Summary

Excellent

GLAXOSMITHKLINE PHARMACEUTICALS did very well, with profits growing faster than sales. This means they're managing costs better.

This analysis provides a snapshot of GLAXOSMITHKLINE PHARMACEUTICALS's financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.